We are live on ! Find out more
SONN

Sonnet BioTherapeutics
SONN

Delisted

SONN was delisted on the 2nd of December, 2025.

Back to rankings

1 hedge funds and large institutions have $1.09M invested in Sonnet BioTherapeutics in 2016 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

31% less capital invested

Capital invested by funds: $1.57M → $1.09M (-$480K)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$24K
2
Goldman Sachs
Goldman Sachs
New York
-$19K
3
TSS
Two Sigma Securities
New York
-$16K
4
VKH
Virtu KCG Holdings
New York
-$12K
5
CG
Cutler Group
California
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
TDC
1
Thompson Davis & Co
Virginia
$314K – – –
Bank of America
2
Bank of America
North Carolina
$205K – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$176K – – –
IC
4
Intersect Capital
California
$100K – – –
BIT
5
BlackRock Institutional Trust
California
$82K – – –
EVC
6
Eidelman Virant Capital
Missouri
$62.4K – – –
GHAM
7
Gilman Hill Asset Management
Connecticut
$49K – – –
CDH
8
Charles D. Hyman
$36K – – –
SI
9
SII Investments
Wisconsin
$24K – – –
CL
10
CSS LLC
Illinois
$18K – – –
Northern Trust
11
Northern Trust
Illinois
$14K – – –
BFA
12
BlackRock Fund Advisors
California
$4K – – –
BIM
13
BlackRock Investment Management
Delaware
$3K – – –
Morgan Stanley
14
Morgan Stanley
New York
$1K – – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
$74 – – –
CG
16
Cutler Group
California
– -$3K – –
Goldman Sachs
17
Goldman Sachs
New York
– -$19K – –
IA
18
IFP Advisors
Florida
– -$2K – –
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
– -$24K – –
TSS
20
Two Sigma Securities
New York
– -$16K – –
VKH
21
Virtu KCG Holdings
New York
– -$12K – –

SONN Hedge Fund Activity: Q1 2016 in Review

1 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Sonnet BioTherapeutics (SONN) for Q1 2016, worth a combined $1.09M — down 31% from $1.57M a quarter earlier.

Fund positioning in SONN was balanced in Q1 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Susquehanna International Group, cutting an estimated $24K.

  • 1 institutional investor held Sonnet BioTherapeutics (SONN) as of Q1 2016, unchanged from Q4 2015.
  • Funds reported $1.09M of Sonnet BioTherapeutics stock for Q1 2016, down 31% quarter-over-quarter.
  • 0 funds opened new Sonnet BioTherapeutics positions in Q1 2016 and 0 closed out.
  • The largest Sonnet BioTherapeutics seller in Q1 2016 was Susquehanna International Group, an estimated $24K sold.

Based on aggregated 13F filings for Q1 2016.